Introduction to ONCOIMMUNOLOGY-MEXICO


Photos from the course: ONCOIMMUNOLOGY-MEXICO Photos

Date: 5-8 October, 2016.

Location: San Miguel de Allende, Guanajuato, MEXICO.

Site: Hotel Misión San Miguel de Allende

  • Supported by the International Union of Immunologists (IUIS), the Latin American Association of Immunology (ALAI) and the Mexican Society of Immunology (SMI), the IUIS-ALAI-SMI ONCOIMMUNOLOGY-MEXICO will be the first international course in its type in Latin America.
  • This event will provide the fundamental knowledge and mechanisms underlying immune responses in cancer, the recent advances and emerging research.
  • Moreover, it will encourage professional discussion on current strategies for therapeutic modulation of the immune system in cancer, between and among the next generation of leading Latin American Immunologists and outstanding national and international scientists.
  • An opportunity for the participants to become acquainted with the most recent developments in the field of Oncology and Immunology and to establish contacts for future collaborations is highly expected.
  • The target audience will include clinical and research fellows, postgraduate students interested and currently performing research in disciplines related to Immunology and Oncology, and scientists or other research professionals from biotechnology and pharmaceutical companies who are involved in developing new therapies in those biomedical fields.
  • All participants will have free access to teaching material via Immunopaedia and are expected to have familiarized themselves with basic and clinical onco-immunology concepts.
  • Table 1 below shows the course lecturer, title of their topic and the link to the section in this module for ease of reference
  • At the end of each section there are multiple choice questions, where you can assess your knowledge as you proceed

Download the Presentation for this section:

 

Table 1: Lecturer, Title and Section to be found in the IMMUNOMEXICO pre-course material

LecturerTitle of lecturePre-course topic in Immunopaedia
Dr. MoharHallmarks of Cancer & EpidemiologyCancer Epidemiology and Etiology
Dr. RecillasGenomics and Epigenetics of Oncological Processes
Dr. RoblesSignalling Pathways in Cancer
Dr. QuinteroBreast Cancer
Dr. MorenoHow Cancer Cells Interact with Immune System-
Dr. OrtizEffector Cell Populations of Anti-tumor Immunity
Dr. SalazarSolid Tumors
Dr. MorenoHow Cancer Cells Interact with Immune SystemT lymphocyte mediated immunity
Dr. OrtizEffector Cell Populations of Anti-tumor Immunity
Dr. VignaliMolecular Mechanisms of Lymphocyte Activation in Cancer
Dr. MorenoHow Cancer Cells Interact with Immune System-
Dr. OrtizEffector Cell Populations of Anti-tumor ImmunityImmune Responses to Cancer
Dr. GajewskiImmune Regulation in Cancer
Dr. GuzmanCancer Stem CellsCancer Stem Cells and Tumor-initiating cells
Dr. Flores-FigueroaTumor Microenvironment: Hematological Malignancies as a Paradigm of StudyTumor Microenvironment
Dr. VignaliMolecular Mechanisms of Lymphocyte Activation in Cancer
Dr. LetarteRole of Endothelial Cells in Tumor Progression
Dr. Fuentes-PananaPathogen and CancerPathogens and Cancer
Dr. CrociVaccination in CancerCancer Immunotherapy
Dr. GalluzziCurrently Available Anti-cancer Immunotherapies
Autophagy and other mechanisms of neoplastic cell control
Dr. BuqueImmunological Effects of Chemotherapy and Targeted Anticancer Agents
Dr. HassanePrecision Cancer Medicine and Neoantigens Discovery
Dr. GoldaracenaAcute Leukaemia Phenotyping: Euroflow PlatformFlow cytometry approaches in cancer
Dr. JuarezData Acquisition in the BD FACSCanto II and Cell Analyses in Infinicyt Software: B-ALL, CLL, MM, PCD
Dr. VadilloCancer Stem & Early Progenitor Cell Flow Cytometry in Breast Cancer, Prostate Cancer, Lung Cancer, Colon Cancer
Data Acquisition and Cell Analyses in the BD FACSCanto II:

 

The material in each section has been edited and compiled by the IMMUNOMEXICO team and IMMUNOPAEDIA (based at the University of Cape Town) and generously contributed by Professor Joseph A. Bellanti from his textbook, “IMMUNOLOGY IV: CLINICAL APPLICATIONS IN HEALTH AND DISEASE” under an agreement between I Care Press Inc, Immunopaedia (University of Cape Town) and the IUIS. The resource materials available for download have been supplied by each lecturer participating in the course.

For those interested in purchasing the printed version of “Bellanti JA (Ed). Immunology IV: Clinical Applications in Health and Disease. I Care Press, Bethesda, MD, 2012”, go to: www.immunologycenter.org or www.amazon.com.

 
 
 
 
 
 
International Union of Immunological SocietiesUniversity of South AfricaInstitute of Infectious Disease and Molecular MedicineElizabeth Glazer Pediatric Aids Foundation